这是描述信息
Location:
Homepage
/
/
Development•Cooperation•Landing Hongqi Pharmaceutical held the 2017 Mid-year Marketing Conference

Development•Cooperation•Landing Hongqi Pharmaceutical held the 2017 Mid-year Marketing Conference

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2017-07-20
  • Views:0

(Summary description)From July 9th to 12th, Shenyang, blue sky and white clouds, without the scorching sun in the south. The sales department of Hongqi Pharmaceutical and the Ministry of Commerce held a mid-year meeting.

Development•Cooperation•Landing Hongqi Pharmaceutical held the 2017 Mid-year Marketing Conference

(Summary description)From July 9th to 12th, Shenyang, blue sky and white clouds, without the scorching sun in the south. The sales department of Hongqi Pharmaceutical and the Ministry of Commerce held a mid-year meeting.

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2017-07-20
  • Views:0
Information
  From July 9th to 12th, Shenyang, blue sky and white clouds, without the scorching sun in the south. The sales department of Hongqi Pharmaceutical and the Ministry of Commerce held a mid-year meeting.
  Mr. Yang Bo, the general manager of Hongqi Pharmaceuticals, analyzed the changes in the external environment to all marketing staff at two meetings. Cooperation. In-depth explanation of our marketing strategy in three aspects.
 
 
1. Development-Hongqi Pharmaceutical must gradually move towards internationalization and marketization
  Hongqi Pharmaceutical has always been an important part of the national tuberculosis prevention and treatment system and has undertaken important social responsibilities. Especially since joining Fosun Pharma Group, it has entered the fast lane of development. How to ensure the continuous supply of anti-tuberculosis drugs and how to provide high-quality products are not only the requirements of the country, but also the responsibility of the Red Flag people.
  In order to accelerate the development of Hongqi, Fosun Pharmaceutical Group has given strong support, not only providing financial support, but also supporting Hongqi Pharmaceutical's reform of the solid preparation production workshop and new version of GMP certification, introducing high-end talents, conducting consistency evaluations, improving product quality, and introducing And develop new anti-tuberculosis drugs.
  The new solid preparation production line project is constructed in strict accordance with WHO standards, and the total investment in plant and equipment construction is about 100 million yuan. Equipped with domestic high-level pharmaceutical equipment to achieve quality and production system software and hardware upgrades. After passing the GMP certification, the new production line plans to continue to optimize and upgrade management, and strive to meet the WHO PQ standards, and lay a solid foundation for going global.
  Hongqi Pharmaceutical is carrying out the first-line anti-tuberculosis drug and FDC consistency evaluation work; to ensure that it reaches the highest domestic quality level, to seize the opportunity for future market development. At the same time, relying on the Group's resource advantages, it carries out raw material reserves, invests in raw material bases, ensures the integrity of the product supply chain, forms a closed-loop integration, and improves the competitiveness of the company.
  At the level of market promotion and brand building, the “Double Thousand” charity event was jointly launched with the China National Tuberculosis Association, undertook to build the China National Tuberculosis Association’s anti-tuberculosis drug supply coordination reserve, and successfully launched the Innovation Alliance-Red Flag "Young Eagle" project. The clinical verification of rifampicin Ⅱ has been carried out in several hospitals, which enriched clinical data for future promotion. All these have established a good brand image for Hongqi Pharmaceutical.
  In terms of new product development and introduction, the company is currently improving first-line anti-tuberculosis drugs and building a second-line multi-drug resistant product line, such as the national first-class new drug PA-824, introducing PAS particles, cycloserine capsules, etc.
  The two major engines of R&D and marketing will promote Hongqi Pharmaceuticals to achieve the company's five-year strategic goals.
2. Cooperation-We should open our minds and establish a multi-level cooperation and win-win system with customers in the industry and even competitors.
  First, establish a multi-level cooperative relationship with the national tuberculosis prevention and control department, do a good job in government affairs, public relations and brand promotion, and actively cooperate with the adjustment of the national tuberculosis prevention and control system. Secondly, establish multi-level cooperation with therapeutic institutions to provide services and support for grassroots doctors, family doctors, and first- and second-tier tuberculosis hospital experts. Third, the marketing department works closely with the sales department, relying on market promotion and brand marketing to enhance corporate influence and quickly drive sales growth. Finally, the Sales Department works closely with the Ministry of Commerce. The Ministry of Commerce provides services and support for sales business expansion through the establishment of a provincial, district, county, and community channel network.
3. Landing——Fix all work on the company's brand and establish an inheritable benefit system for the company.
  Business should strengthen channel construction, and control chain pharmacies and retail terminals on the basis of serving self-operated hospitals and military stations. All departments should solidify all work and investment on the brand, and establish a system of inheritable interests for the company.
  Mr. Yang's speech clearly tells us where we are going? how to go? It points out the direction for the next step of the marketing team.
  During the meeting, all members of the Sales Department and the Ministry of Commerce completed reports one by one on the main work in the first half of the year, achievements, existing problems, and key points and detailed plans for the second half of the year. General Manager Li Shaowei of the Sales Department and General Manager Li Wenzhi of the Commerce Department also gave comments and guidance according to the different situations of the employees, and conducted a comprehensive summary of the work in the first half of the year and detailed deployment of the work plan in the second half of the year from a departmental perspective. Pointed out the path for the department's work.
 
 
 
  During the conference, all staff received a two-day training, including one-day regional development of pharmaceutical sales elites, major customer maintenance and new general drug channel sales strategies, as well as product knowledge, new financial policies, EXCEL and PPT skills improvement. Through the training, everyone's awareness of tuberculosis and product knowledge, marketing, micro-market management, policy information, etc. has been improved.
 
 
 
  In this meeting, analyzing problems, finding gaps, boosting morale, and clarifying goals requires all marketing colleagues to resolutely implement and land, and look forward to another good result in 2017.
 

Scan the QR code to read on your phone

Copyright hongqipharma.com All rights reserved     Powered by:300.cn Shenyang    辽icp备12005917号    (辽)-非经营性-2018-0012 

Add:Shenyang Hunnan New District envelope 6th Street    Tel:024-23786268-8012  Fax:024-23786263